Mycronic AB (publ)

Hello and welcome to the presentation of Micronic's Q1 report. My name is Sven Kjetkovic, I'm the Director of Investor Relations at Micronic. With me I have Micronic's CEO and President Anders Lindqvist and CFO and Senior Vice President Corporate Development Pierre Brouchon, who will be presenting today. We have made a change to the Q&A session later in the presentation. There are no phone numbers to dial this time. If you want to ask questions during the Q&A, please click a request to speak button that will be visible during the Q&A in order to enter the queue. Ask your question when introduced by me. We will only be broadcasting your voice. With that, I hand over to Anders. Please go ahead and present my Chronix Q1 report.

Okay, thank you very much, Sven. This is what we will present today. So we will start with the quarter one, in short, summary of that, and then also the divisional development. Pierre Brosson, CFO, will go through the financials. talk a little bit on our progress on sustainability. And then as Sven said, we will end with the question and answer session. At the end, in the material in the presentation, you will also find an appendix that we will not present, which is the market update with all the statistics from the market where we operate in. When it comes to the first quarter, the highlight of the quarter is that we have had a continuous very high and good order intake. We had an increase of 12% compared to the same quarter last year, up to a little bit above 1.6 billion Swedish kronor. It's driven by the order intake in patent generators. And you can put that in relation also to last year revenue, which was 5.1 billion. And then you see that the 1.6 billion level is a really strong order intake number for the quarter. At the same time, we also had an increase in sales by 7% to 1.2. Quite a lot of that was driven by currency, so 2% organic growth in that number. EBIT ended at 182 million compared to 206. And for comparison reasons, we have also, as we say here, that we had the divestment, we had AEI in the business same quarter last year. So if we adjust for that, it's a flat development of EBIT and corresponding to a margin of 15%. So we have had also good order intake previous quarters, as you have seen, hopefully. And we have a record high now backlog of close to 4 billion at the end of the quarter. And at the end of the quarter, we have 30 systems in the backlog. And then, as an additional highlight, we had also two more orders after the quarter of two pieces of SLX mask writers. So backlog is extremely strong, as you can understand. If we go a little bit more in detail on the different divisions, starting with the patin generators, we can see that we still have a very good market for photomask in semiconductors. And to say here that it's in the mature design nodes that remains strong. And the mature design nodes are the ones which we address with our SLX mask writers. So it's a good place to be at. Also display has been good. We had, if you look at the order intake, we had eight systems for the quarter. Precision 8 Evo is a display writer and then also an FPS 6100 and six mask writers for the Semicon industry SLX. So very strong order intake, 113% up compared to the same quarter. last year. We also delivered some systems, and we had an increase of sales of 10%, reaching 351 million. And in the delivery, we delivered three pieces of equipment, one precision light eight Evo FPS 6101 SLX. And we should have delivered one more SLX in the quarter, which was moved from quarter one to quarter two. So it will be delivered this quarter instead. Gross margin was okay at 62% and EBIT reached 150. So backlog of close to 3 billion in this one. And the end of the quarter, we had 30 systems as said. If we move on to the other division, another division, Hyflex, we had a decent start to 2023. We have seen that we have very good demand in Europe and also in North America and a lower level in China. And a lower level in China, you will see in the other divisions as well, actually. It's kind of a common theme here. But in the beginning of the quarter in January, there is an annual trade show in San Diego, which is the one of the big one in the electronics assembly industry, which had a lot of visitors, a lot of interest and a lot of activity, which is really showing that there is there is a good demand and a good interest from the special than the North American market, including Mexico as well. We continue. So on the high flex division. So we had an order decline of 3% and Also an increase of sales with 11% up to 322 million. Gross margin quite stable and a good gross margin of 40%. EBIT ended at 23%, which is a little bit up compared to last year. And a backlog of 180 million. So it's kind of as expected start to the year. In the high volume division, We had a little bit of slow pace of investments when it comes to consumer electronics manufacturers. And even though the COVID restrictions in China have been lifted, we have seen that this industry has not yet really recovered when it comes to investments. It's still hesitating a little bit, but we expect that to come. You can see that in the order intake, we had a decline of 41%. To compensate, we focus on new areas. One of them is the electrical vehicle industry, which is very strong, especially in China. And also looking at more aggressive geographic expansion outside of China. We have got an initial order from a production facility outside of China, but belonging to a Chinese manufacturer of electrical vehicles. Sales were flat, 367 million, same as last year and we have an increase in gross margin and This is what they have a better mix. We have a better delivery, better gross margin in the deliveries we have had. And also we have worked with efficiency improvement in this division, resulting in that the EBIT improved to 64 million. And in that 64, we also had a negative impact that we have bad debt provisions of seven millions in that. So backlog at the end of the quarter, a little bit more than 600 million. When it comes to global technologies, we have two lines of business here. One is electrical testing of PCBs and substrates and the other one is die bonding, addressing mainly the telecommunication market. And we have seen a little bit of slowdown in both. of these markets, both related to the Chinese market as a whole, but also that in the market of data and telecom, a little bit of decline and resulting in that our ordering intake decreased by 27%. If you make a fair comparison, because we had this AI business in the quarter last year, it's a decline of 25%, so almost The same, a little bit an increase in sales but mainly related to the currency exchange effect here. Gross margin flat at 35% and EBIT down to 3%. Million. Also here we have a comparison effect with the AI business that we had in the business last year, which had an impact of 25 million of the previous quarter last year, or the same quarter last year, previous year. Backlog ending at 236 million. When it comes to our outlook, we have made no change here. We still believe that we will reach a sales of 5.5 billion at the end of the year. So nothing to update there. So by that I will hand over to Pierre Sifo to explain the numbers a little bit more in detail.

Good morning everyone from my side as well. We will go a little bit deeper in some of the numbers here. If we look at it we continue to have a fourth quarter in a row of continued growth on the revenue side and we are now at 5.2 billion Swedish rolling 12 months. The margin is at 17% on a rolling 12-month basis and relatively flat development lately. The aftermarket revenue continued to increase since two years, quarter on quarter, when looking at the rolling 12-month numbers and this is of course a good thing for us. Moving a little bit into the quarter on quarter comparisons. We have now six quarters in a row above one billion in revenue. So we are establishing a good level and this is the fourth quarter on 1.2 billion, so also there is good. Even if the organic growth in the quarter was modest with only 2%. We had a little bit weaker EBIT margin than the last couple of quarters. And if we compare year on year, it's affected by the AI divestment we had last year, which gave a gain of 25 million in the Q1 numbers of 2022. We also have higher costs on what we call group functions and some sometimes referred to group functions, et cetera, where we have also eliminations. And this is largely driven by our high activity in business development projects at the moment. This made us end the quarter at an EBIT margin of 15%. If we look at a bridge of where the components make up the difference between the quarter one last year and the quarter one this year, we had in volume and gross margin effect, positive development, largely driven from PG, where we had a little bit of volume and a little bit of improved margin. We had also improved margins in the high volume division in particular. If we look at the R&D, we are investing in the organic opportunities that we see. We had slight increase across in R&D, but in particular in division high flex in the quarter compared to the same quarter last year. On the marketing and sales side, there we have the increased business development projects. We have also the provision for bad debt in division HV that Anders mentioned earlier. This is a provision which we make as a calculation based on the aging of receivables and it's not attributable to a specific loss. We haven't basically had any concluded losses on the receivables but we do see a delay in payments particularly related in to the high volume division. G&A some small increases and in this other position the main difference on last year is the 25 million in related to the AEI divestment last year we have spoken about a few times already. If we then move into the other dimension and look at it division by division, you can see that we have improvements in the pattern generators related to volume and gross margin, as mentioned. We have in high flex a little bit increase in volume in the quarter. And on the negative side here, we had a little bit higher R&D spend. In high volume, we have improved the gross margin in particular. And in the global technologies, then the sales of the AI is recorded. And finally, in the group functions, et cetera, largely the business development. And I should also mention a very low comparative number for the same quarter of last year. The average for the year, the difference is about 10 million less than the 34 noted here. If we look at the cash flow, we have strong cash flow, both from the result and from improved working capital, positive development of the receivables compared to end of the year. And also a little bit higher payables than we had at that point. On the investing activities we had last year in the comparative number the sale of AEI which generated 215 million. So this is a normal level of our investments you could say. and no other big differences in the financing activities and the exchange rates. We have a strong cash position and the cash as such was 1.6 billion almost and adjusted for the IFRS etc. We have a net cash position of 1.3 billion at the end of the quarter. With that, I hand the word back to Anders.